J 2020

Natural compounds with dual antimicrobial and anti-inflammatory effects

SYCHROVÁ, Alice, Ivana KOLÁRIKOVÁ, Milan ŽEMLIČKA a Karel ŠMEJKAL

Základní údaje

Originální název

Natural compounds with dual antimicrobial and anti-inflammatory effects

Autoři

SYCHROVÁ, Alice (203 Česká republika, domácí), Ivana KOLÁRIKOVÁ, Milan ŽEMLIČKA (203 Česká republika, domácí) a Karel ŠMEJKAL (203 Česká republika, garant, domácí)

Vydání

Phytochemistry reviews, Dordrecht, Springer, 2020, 1568-7767

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.374

Kód RIV

RIV/00216224:14160/20:00118254

Organizační jednotka

Farmaceutická fakulta

UT WoS

000543051200001

Klíčová slova anglicky

Alkaloids; Antibacterial; Anti-inflammatory; Chalcones; Coumarins; Dual inhibitors; Flavanones; Flavones; Flavonols; Isoflavonoids; Lignans; Other substances; Prenylated flavones; Synergy; Terpenoids

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 6. 4. 2021 13:34, Mgr. Hana Hurtová

Anotace

V originále

Increasing antimicrobial resistance, together with the occurrence of side effects of NSAIDs or glucocorticoids represents certain motivation to search for new natural dual antimicrobial and anti-inflammatory drugs. We here present selected natural compounds, possessing both antimicrobial and anti-inflammatory activity. The review contains also the information about structure-activity relationships with respect to natural or semisynthetic origin of compounds and synergy effects between natural dual inhibitors and commercially available antibiotics. Data published from 2000 to 2018 were obtained using databases Google Scholar, Science Direct and Web of Science, and searching keywords such asalkaloids,anti-inflammatory activity, antimicrobial activity, chalcones, coumarins, flavonoids, IC50, lignans, MIC, natural compounds,synergistic effectandterpenoids, alone or in a combination. The primary criteria for the selection of appropriate compounds were the MICs and IC(50)s used for a quantification of effects. The natural compounds with activity close to the reference substances or showing MIC up to 32 mu g ml(-1), and IC(50)of anti-inflammatory effect up to 15 mu M were considered as promising. When available, information about in vivo testing was included. Reviewed dual inhibitors can represent modern therapeutic approach, especially when the process of inflammation is followed by a secondary bacterial infection. Benefits of dual inhibitors are based on better compliance of patients, decreased number of side effects and extended spectrum of action. [GRAPHICS] .